Assessment of Ovarian Reserve in the Treatment of Ovarian Endometrioma With Cystectomy or Argon Plasma Coagulation: A Aandomized Clinical Trial

Inclusion Criteria: * Symptomatic patients (pain and/or infertility) affected by ovarian endometriomas (unilateral or bilateral). * Age between 18 and 40 years. * Ultrasound diagnosis of one or more mono- or bilateral endometriotic cysts, with a maximum overall diameter (per ovary) ≤ 80 mm and at least one cyst diameter ≥ 20 mm. * Use of hormonal therapy for at least 1 month prior to surgery. * Willingness to undergo follow-up at 40-60 days and 12 months, according to clinical practice. * Willingness to receive postoperative hormonal therapy, according to clinical practice, to minimize the risk of recurrence. * Written informed consent obtained. Exclusion Criteria: * History of unilateral ovariectomy/adnexectomy or hysterectomy. * Ultrasound evidence of other non-endometriotic ovarian cysts requiring surgical removal. * Atypical endometrioma or ultrasound suspicion of malignancy. * Previous surgery on one or both ovaries within 12 months prior to surgery. * Known or suspected active oncological disease. * Inability to undergo transvaginal ultrasound examination (patients with intact hymen).